Dr. Max Group, a pharmacy management operator in Europe, completed the acquisition of Neo Apotek, an Italian pharmacy, for $435m. "This strategic acquisition allows us to combine the best of both entities, contributing to the enhancement of Dr. Max's established experience and structure, as well as the focus on excellence and innovation for which Dr. Max is known in Europe. With the acquisition of Neo Apotek, we solidify our commitment to a path of rapid development in Italy, a journey that began with the opening of the first Dr. Max pharmacy in 2018. Our vision is clear: Dr. Max is already a market leader in numerous European countries, and we are determined to achieve a leadership position in Italy as well. The acquisition of Neo Apotek represents a significant milestone in this journey, a crucial piece for our growth and for all the people who work with us,” Leonardo Ferrandino, Dr. Max Group CEO.